131 West Street
Danbury, CT 06810
The vision of the Western Connecticut Health Network’s (WCHN) Rudy L. Ruggles Biomedical Research Institute (RRBRI) is to advance the health of the community by performing innovative translational research and putting into practice concepts of precision medicine with the goal of improving value-based medicine. RRBRI’s 17,000-square-facility houses state-of-the-art laboratory equipment for translational research programs that focus on diseases concerning our immediate community such as cancer and Lyme disease and complement ongoing epidemiologic studies and clinical trials conducted at WCHN’s hospitals in Danbury, New Milford, and Norwalk. RRBRI encourages scientific collaboration and clinical partnerships with leading research organizations and the biopharmaceutical and medical device industries to pioneer new discoveries in precision medicine technologies and foster creative solutions.